Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$13.01
$14.76
$10.09
$18.79
$8.61B1.3359.44 million shs63.56 million shs
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$63.53
-0.2%
$63.61
$42.52
$68.64
$129.76B0.237.38 million shs7.05 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Airlines Group Inc. stock logo
AAL
American Airlines Group
0.00%-0.91%-12.27%-15.85%+0.77%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.00%-4.97%-0.52%+12.83%+37.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$13.01
$14.76
$10.09
$18.79
$8.61B1.3359.44 million shs63.56 million shs
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$63.53
-0.2%
$63.61
$42.52
$68.64
$129.76B0.237.38 million shs7.05 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Airlines Group Inc. stock logo
AAL
American Airlines Group
0.00%-0.91%-12.27%-15.85%+0.77%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.00%-4.97%-0.52%+12.83%+37.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Airlines Group Inc. stock logo
AAL
American Airlines Group
2.29
Hold$18.5342.41% Upside
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.56
Moderate Buy$66.334.42% Upside

Current Analyst Ratings Breakdown

Latest AAL and BMY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Lower Price TargetEqual Weight$19.00 ➝ $14.00
9/10/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Lower Price TargetBuy$18.00 ➝ $17.00
9/10/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Reiterated RatingHold$60.00 ➝ $65.00
8/26/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
DowngradeSell (D+)Sell (D)
8/24/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Lower Price TargetBuy$24.00 ➝ $16.00
8/21/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
DowngradeStrong-BuyHold
8/18/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
UpgradeHold (C+)Buy (B-)
8/11/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
UpgradeSell (D)Sell (D+)
8/5/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Initiated CoverageMarket PerformStrong-Buy
8/5/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Initiated CoverageHoldBuy
8/5/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
DowngradeBuyNeutral
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$54.63B0.16$3.72 per share3.50($5.65) per share-2.30
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.19B2.69$8.11 per share7.83$9.09 per share6.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$111M-$0.49N/A6.08N/A-0.56%-9.11%-0.27%10/22/2026 (Estimated)
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$7.05B$4.5413.999.860.3018.87%66.90%14.74%10/29/2026 (Estimated)

Latest AAL and BMY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.60$2.04+$0.44$1.62$11.74 billion$12.97 billion
7/23/2026Q2 2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$0.03$0.15+$0.12$0.11$16.70 billion$16.74 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
American Airlines Group Inc. stock logo
AAL
American Airlines Group
N/AN/A-100.00%N/AN/A
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.523.97%+1.61%55.51%17 Years

Latest AAL and BMY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/17/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.634.34%7/2/20267/2/20268/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Airlines Group Inc. stock logo
AAL
American Airlines Group
N/A
0.53
0.42
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1.89
1.53
1.38

Institutional Ownership

CompanyInstitutional Ownership
American Airlines Group Inc. stock logo
AAL
American Airlines Group
52.44%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%

Insider Ownership

CompanyInsider Ownership
American Airlines Group Inc. stock logo
AAL
American Airlines Group
0.70%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Airlines Group Inc. stock logo
AAL
American Airlines Group
139,100661.97 million657.34 millionOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
32,5002.04 billion2.04 billionOptionable

Recent News About These Companies

Zacks Research Has Positive Outlook of BMY FY2026 Earnings
RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline
Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline
Scotiabank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Airlines Group stock logo

American Airlines Group NASDAQ:AAL

$13.01 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$12.88 -0.13 (-0.96%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. It operates a mainline fleet of 965 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.

Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$63.52 -0.12 (-0.18%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$63.88 +0.35 (+0.55%)
As of 04:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.